Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,385,173 papers from all fields of science
Search
Sign In
Create Free Account
phenglutarimide
Known as:
2-(2-(diethylamino)ethyl)-2-phenylglutarimide
, phenylglutarimide
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (2)
Cholinergic Antagonists
Glutethimide
analogs & derivatives
Narrower (1)
phenglutarimide hydrochloride
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Stereoselectivity at muscarinic receptor subtypes: observations with the enantiomers of phenglutarimide.
G. Lambrecht
,
R. Feifel
,
E. Mutschler
Chirality
1989
Corpus ID: 30250886
The affinity of the enantiomers of phenglutarimide at three muscarinic receptor subtypes was examined in vitro using field…
Expand
1967
1967
Rapid determination of glutethimide (Doriden) by gas-liquid chromatography.
S. Winsten
,
D. Brody
Clinical Chemistry
1967
Corpus ID: 6945403
A rapid simple gas liquid chromatographic technic has been developed for the identification and quantitation of glutethimide in…
Expand
1960
1960
[Phenglutarimide in the medical treatment of parkinsonism].
D. Brage
La Semana medica
1960
Corpus ID: 33978587
1959
1959
Bilan des effets correcteurs du C. 10870 (phenglutarimide) au cours des cures neuroleptiques.
L. Vallade
,
L. Merlin
1959
Corpus ID: 146868059
1959
1959
[Report of the corrective effects of C. 10870 (phenglutarimide) during neuroleptic therapy].
L. Vallade
,
L. Merlin
Annales Medico-Psychologiques
1959
Corpus ID: 29354449
1958
1958
[Aturban (phenglutarimide), a new therapeutic drug for parkinsonism; comparative investigation on the therapy of parkinsonism].
R. Battegay
Swiss medical weekly
1958
Corpus ID: 41621984
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE